[
    [
        {
            "time": "2018-01-03",
            "original_text": "US Indexes Close Higher Wednesday With China Trade Deal Signing",
            "features": {
                "keywords": [
                    "Indexes",
                    "Close",
                    "Higher",
                    "China",
                    "Trade",
                    "Deal",
                    "Signing"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance",
                    "international trade"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-06-15",
            "original_text": "Bristol-Myers' Opdivo-Yervoy sBLA for NSCLC Accepted by FDA",
            "features": {
                "keywords": [
                    "Bristol-Myers",
                    "Opdivo-Yervoy",
                    "sBLA",
                    "NSCLC",
                    "FDA"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-07-22",
            "original_text": "Glaxo, Pfizer Executives Out of Step on Consumer Unitâ€™s Future",
            "features": {
                "keywords": [
                    "Glaxo",
                    "Pfizer",
                    "Executives",
                    "Consumer",
                    "Unit",
                    "Future"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "consumer goods"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-01-16",
            "original_text": "Influencers Transcript: Robert F. Kennedy, Jr., January 16, 2020",
            "features": {
                "keywords": [
                    "Influencers",
                    "Transcript",
                    "Robert",
                    "F.",
                    "Kennedy",
                    "Jr."
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 3,
                "Impact": 2,
                "Duration": 2,
                "Entity_Density": 2,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-10",
            "original_text": "Hedge fund veteran looks to cash in on biotech boom",
            "features": {
                "keywords": [
                    "Hedge",
                    "fund",
                    "veteran",
                    "biotech",
                    "boom"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "financial services",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]